Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vaccines, Virus-Like Particle | 7 | 2019 | 312 | 3.65 | Why? |
| Starch | 2 | 2018 | 21 | 1.45 | Why? |
| Animal Feed | 2 | 2018 | 72 | 1.37 | Why? |
| Horses | 2 | 2018 | 474 | 1.25 | Why? |
| Plasma Cells | 2 | 2019 | 464 | 1.23 | Why? |
| Glycoproteins | 2 | 2019 | 615 | 1.03 | Why? |
| Allergens | 2 | 2019 | 728 | 0.93 | Why? |
| Adjuvants, Immunologic | 4 | 2019 | 1709 | 0.91 | Why? |
| Toll-Like Receptor 7 | 2 | 2019 | 402 | 0.89 | Why? |
| Cancer Vaccines | 2 | 2019 | 136 | 0.85 | Why? |
| Germ Cells | 1 | 2019 | 39 | 0.77 | Why? |
| Interleukins | 2 | 2018 | 762 | 0.74 | Why? |
| Edible Grain | 1 | 2018 | 26 | 0.74 | Why? |
| alpha-Amylases | 1 | 2017 | 10 | 0.73 | Why? |
| Interleukin-5 | 1 | 2018 | 138 | 0.71 | Why? |
| Dairying | 1 | 2017 | 46 | 0.70 | Why? |
| Vaccination | 7 | 2020 | 19050 | 0.69 | Why? |
| Insect Bites and Stings | 1 | 2018 | 63 | 0.69 | Why? |
| Allolevivirus | 3 | 2017 | 5 | 0.68 | Why? |
| Antibody Affinity | 2 | 2019 | 1078 | 0.67 | Why? |
| Horse Diseases | 1 | 2018 | 101 | 0.66 | Why? |
| Amyloid beta-Peptides | 1 | 2018 | 185 | 0.66 | Why? |
| Th2 Cells | 1 | 2020 | 680 | 0.63 | Why? |
| Toll-Like Receptors | 1 | 2019 | 365 | 0.63 | Why? |
| Milk | 1 | 2017 | 158 | 0.63 | Why? |
| Antibody Formation | 2 | 2020 | 4038 | 0.61 | Why? |
| Dendritic Cells | 3 | 2019 | 1330 | 0.60 | Why? |
| Virion | 3 | 2019 | 1444 | 0.59 | Why? |
| Lactation | 1 | 2017 | 361 | 0.57 | Why? |
| Immunodominant Epitopes | 1 | 2020 | 813 | 0.56 | Why? |
| Mast Cells | 1 | 2018 | 370 | 0.55 | Why? |
| Amino Acids | 1 | 2018 | 552 | 0.54 | Why? |
| Receptors, IgG | 1 | 2018 | 578 | 0.53 | Why? |
| Vaccines | 4 | 2020 | 3692 | 0.52 | Why? |
| Eosinophils | 1 | 2020 | 848 | 0.52 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.50 | Why? |
| Antibodies | 1 | 2020 | 846 | 0.50 | Why? |
| Transcription, Genetic | 1 | 2019 | 1326 | 0.50 | Why? |
| Papillomaviridae | 1 | 2017 | 404 | 0.50 | Why? |
| Cattle | 1 | 2017 | 1336 | 0.50 | Why? |
| Mice, Inbred C57BL | 6 | 2019 | 5542 | 0.48 | Why? |
| Nanoparticles | 3 | 2018 | 2040 | 0.46 | Why? |
| RNA | 1 | 2019 | 1278 | 0.44 | Why? |
| Hepatitis B virus | 1 | 2017 | 882 | 0.40 | Why? |
| Dermatitis, Atopic | 1 | 2018 | 714 | 0.40 | Why? |
| Toll-Like Receptor 8 | 1 | 2010 | 102 | 0.40 | Why? |
| Epitopes | 2 | 2019 | 4113 | 0.40 | Why? |
| B-Lymphocytes | 3 | 2019 | 4418 | 0.39 | Why? |
| Antibodies, Monoclonal | 4 | 2018 | 8041 | 0.39 | Why? |
| Animals | 20 | 2019 | 78931 | 0.37 | Why? |
| Germinal Center | 2 | 2019 | 332 | 0.37 | Why? |
| Alzheimer Disease | 1 | 2018 | 1020 | 0.37 | Why? |
| Antibodies, Protozoan | 3 | 2017 | 121 | 0.36 | Why? |
| Diet | 2 | 2018 | 2052 | 0.36 | Why? |
| B-Lymphocyte Subsets | 1 | 2010 | 372 | 0.36 | Why? |
| Melanoma | 1 | 2019 | 1229 | 0.35 | Why? |
| Hypersensitivity | 1 | 2018 | 1137 | 0.34 | Why? |
| Viral Vaccines | 2 | 2020 | 7560 | 0.34 | Why? |
| Mice | 11 | 2019 | 21357 | 0.33 | Why? |
| Malaria Vaccines | 2 | 2017 | 90 | 0.32 | Why? |
| Mammals | 1 | 2008 | 315 | 0.31 | Why? |
| Plasmodium vivax | 2 | 2017 | 154 | 0.30 | Why? |
| Malaria, Vivax | 2 | 2017 | 152 | 0.30 | Why? |
| Peptide Library | 1 | 2008 | 564 | 0.29 | Why? |
| Skin Neoplasms | 1 | 2019 | 1679 | 0.29 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.29 | Why? |
| Zika Virus | 1 | 2018 | 1924 | 0.29 | Why? |
| Dietary Supplements | 1 | 2017 | 2251 | 0.29 | Why? |
| Biosensing Techniques | 2 | 2018 | 2116 | 0.28 | Why? |
| Immunoglobulin E | 2 | 2018 | 557 | 0.28 | Why? |
| Mice, Inbred BALB C | 4 | 2019 | 5814 | 0.27 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.27 | Why? |
| Zika Virus Infection | 1 | 2018 | 1920 | 0.27 | Why? |
| Cell Differentiation | 3 | 2019 | 1338 | 0.27 | Why? |
| Immunogenicity, Vaccine | 1 | 2018 | 4624 | 0.25 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2019 | 5837 | 0.25 | Why? |
| Saliva | 1 | 2018 | 4679 | 0.22 | Why? |
| Membrane Glycoproteins | 1 | 2010 | 2273 | 0.21 | Why? |
| Capsid Proteins | 2 | 2017 | 365 | 0.21 | Why? |
| Ligands | 2 | 2019 | 1300 | 0.21 | Why? |
| Mice, Knockout | 2 | 2019 | 1815 | 0.20 | Why? |
| Glutaredoxins | 1 | 2019 | 15 | 0.20 | Why? |
| Virus Diseases | 1 | 2017 | 3779 | 0.20 | Why? |
| Antigens, Viral | 1 | 2017 | 6298 | 0.20 | Why? |
| Thioredoxins | 1 | 2019 | 25 | 0.20 | Why? |
| Protein Aggregates | 1 | 2018 | 51 | 0.19 | Why? |
| Cucumovirus | 1 | 2018 | 1 | 0.19 | Why? |
| Antigen Presentation | 2 | 2019 | 524 | 0.19 | Why? |
| Digestion | 1 | 2018 | 18 | 0.19 | Why? |
| Basophils | 1 | 2019 | 179 | 0.19 | Why? |
| Postprandial Period | 1 | 2018 | 45 | 0.18 | Why? |
| Immunoglobulin G | 3 | 2019 | 21571 | 0.18 | Why? |
| Fats | 1 | 2017 | 5 | 0.18 | Why? |
| Ceratopogonidae | 1 | 2018 | 23 | 0.18 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.18 | Why? |
| Signal Transduction | 2 | 2019 | 7207 | 0.18 | Why? |
| Serum Albumin, Bovine | 1 | 2017 | 40 | 0.18 | Why? |
| Milk Proteins | 1 | 2017 | 47 | 0.18 | Why? |
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2017 | 31 | 0.18 | Why? |
| Immunotherapy | 2 | 2019 | 2421 | 0.18 | Why? |
| Antigens, Neoplasm | 1 | 2019 | 230 | 0.17 | Why? |
| ADAMTS13 Protein | 1 | 2021 | 363 | 0.17 | Why? |
| Toll-Like Receptor 9 | 1 | 2017 | 72 | 0.16 | Why? |
| Chemokine CCL2 | 1 | 2019 | 389 | 0.16 | Why? |
| Immunologic Memory | 2 | 2019 | 3362 | 0.16 | Why? |
| Lymphocytic choriomeningitis virus | 1 | 2017 | 98 | 0.16 | Why? |
| Antigens, Protozoan | 1 | 2017 | 121 | 0.16 | Why? |
| Whole Exome Sequencing | 1 | 2019 | 437 | 0.16 | Why? |
| Purpura, Thrombotic Thrombocytopenic | 1 | 2021 | 284 | 0.16 | Why? |
| Antibodies, Blocking | 1 | 2017 | 174 | 0.16 | Why? |
| Nanotubes, Carbon | 1 | 2017 | 71 | 0.16 | Why? |
| Gene Silencing | 1 | 2017 | 213 | 0.16 | Why? |
| Protozoan Proteins | 1 | 2017 | 205 | 0.16 | Why? |
| Bone Marrow | 1 | 2019 | 492 | 0.15 | Why? |
| Protein Binding | 3 | 2021 | 11430 | 0.15 | Why? |
| CpG Islands | 1 | 2017 | 230 | 0.15 | Why? |
| Cell Proliferation | 3 | 2019 | 1973 | 0.15 | Why? |
| Antigen-Antibody Complex | 1 | 2017 | 408 | 0.15 | Why? |
| Antigens | 1 | 2017 | 267 | 0.15 | Why? |
| Antibodies, Neutralizing | 2 | 2020 | 25288 | 0.15 | Why? |
| Hepatitis B Vaccines | 1 | 2017 | 245 | 0.15 | Why? |
| Random Allocation | 1 | 2018 | 773 | 0.15 | Why? |
| Tears | 1 | 2019 | 400 | 0.14 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2019 | 552 | 0.14 | Why? |
| Spleen | 1 | 2019 | 877 | 0.14 | Why? |
| von Willebrand Factor | 1 | 2021 | 668 | 0.14 | Why? |
| Recombinant Proteins | 2 | 2019 | 3786 | 0.14 | Why? |
| Blood-Brain Barrier | 1 | 2018 | 531 | 0.14 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.13 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.13 | Why? |
| Carrier Proteins | 1 | 2017 | 513 | 0.13 | Why? |
| Fertility | 1 | 2017 | 367 | 0.13 | Why? |
| Immunization | 2 | 2019 | 2019 | 0.12 | Why? |
| Electrochemical Techniques | 1 | 2017 | 406 | 0.12 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.12 | Why? |
| Desensitization, Immunologic | 1 | 2018 | 574 | 0.12 | Why? |
| Cats | 1 | 2019 | 1890 | 0.12 | Why? |
| Papillomavirus Vaccines | 1 | 2017 | 405 | 0.12 | Why? |
| Receptors, Interleukin-21 | 1 | 2010 | 6 | 0.11 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.11 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.11 | Why? |
| Cells, Cultured | 2 | 2019 | 5835 | 0.10 | Why? |
| T-Lymphocytes | 2 | 2018 | 6670 | 0.10 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.10 | Why? |
| Gene Products, env | 1 | 2010 | 74 | 0.10 | Why? |
| Cell Line, Tumor | 1 | 2019 | 3608 | 0.10 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.10 | Why? |
| Equipment Design | 2 | 2018 | 3095 | 0.10 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.10 | Why? |
| Humans | 22 | 2021 | 930598 | 0.10 | Why? |
| Chronic Disease | 1 | 2004 | 5139 | 0.09 | Why? |
| Sindbis Virus | 1 | 2008 | 32 | 0.09 | Why? |
| Precision Medicine | 1 | 2019 | 1477 | 0.09 | Why? |
| Drug Evaluation, Preclinical | 1 | 2019 | 3347 | 0.08 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.08 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.08 | Why? |
| Autoantibodies | 1 | 2018 | 2094 | 0.08 | Why? |
| Cross Reactions | 1 | 2018 | 4374 | 0.08 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2010 | 497 | 0.08 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.08 | Why? |
| Immunity, Innate | 2 | 2017 | 6570 | 0.08 | Why? |
| Nicotine | 1 | 2008 | 213 | 0.07 | Why? |
| Viral Envelope Proteins | 1 | 2018 | 3539 | 0.07 | Why? |
| Universities | 1 | 2021 | 4374 | 0.07 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.07 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Gene Expression Regulation, Viral | 1 | 2010 | 925 | 0.07 | Why? |
| Female | 10 | 2021 | 380317 | 0.07 | Why? |
| Disease Models, Animal | 2 | 2019 | 10998 | 0.07 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 5002 | 0.05 | Why? |
| Viral Nonstructural Proteins | 1 | 2018 | 4810 | 0.05 | Why? |
| Flow Cytometry | 1 | 2008 | 2393 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Nitrohydroxyiodophenylacetate | 1 | 2017 | 1 | 0.05 | Why? |
| Leukocytes, Mononuclear | 1 | 2008 | 2115 | 0.05 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2010 | 2262 | 0.05 | Why? |
| Secondary Prevention | 1 | 2004 | 762 | 0.05 | Why? |
| Receptors, IgE | 1 | 2017 | 26 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2021 | 867 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Academies and Institutes | 1 | 2021 | 539 | 0.04 | Why? |
| Melanoma, Experimental | 1 | 2017 | 57 | 0.04 | Why? |
| Coculture Techniques | 1 | 2017 | 258 | 0.04 | Why? |
| Dielectric Spectroscopy | 1 | 2017 | 75 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Protective Clothing | 1 | 2020 | 468 | 0.04 | Why? |
| Electrodes | 1 | 2017 | 203 | 0.04 | Why? |
| Germany | 2 | 2021 | 9196 | 0.04 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.03 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.03 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2019 | 2739 | 0.03 | Why? |
| Brain | 1 | 2008 | 5133 | 0.03 | Why? |
| Drug Carriers | 1 | 2017 | 590 | 0.03 | Why? |
| Vaccines, Subunit | 1 | 2017 | 1088 | 0.03 | Why? |
| Limit of Detection | 1 | 2017 | 2698 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Lymphocyte Activation | 1 | 2017 | 2742 | 0.02 | Why? |
| Interferon-gamma | 1 | 2017 | 2711 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.01 | Why? |
| Male | 3 | 2021 | 367725 | 0.01 | Why? |
| Biomarkers | 1 | 2019 | 23361 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Adult | 1 | 2020 | 244371 | 0.00 | Why? |
Bachmann's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(216)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(111)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_